Black Diamond Therapeutics, Inc.·4

Feb 15, 5:45 PM ET

Ni Fang 4

4 · Black Diamond Therapeutics, Inc. · Filed Feb 15, 2024

Insider Transaction Report

Form 4
Period: 2024-02-14
Ni Fang
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-14+200,000200,000 total
    Exercise: $4.86Exp: 2034-02-13Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on February 14, 2025, with the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    form4-02152024_100235.xmlPrimary